Legal News & Industry Insights
Stay informed with the latest developments in the legal industry. From emerging trends and landmark rulings to career insights for attorneys and legal professionals, this curated feed delivers the news that matters most to your practice and career path.
Gibson Dunn Secures Second Temporary Restraining Order Win for Edelman in Two Months, Obtaining Broad Relief to Halt Competitor’s Ongoing Client Poaching Scheme
On May 11, 2026, Gibson Dunn successfully represented our client Edelman Financial Engines in the U.S. District Court for the...
BCLP advises EEP on investment in Venezia Football Club
Entrepreneur Equity Partners (EEP) received advice from BCLP on the expansion of its investment in VFC NEWCO 2023, LLC, the...
Gibson Dunn Advises BioCryst Pharmaceuticals on $400 Million Debt Financing for Acquisition of Astria Therapeutics
In relation to a $400 million senior secured term loan arrangement that partially funded the purchase of Astria Therapeutics, Inc.,...
Gibson Dunn Advises Galecto, Inc. on Establishing At-the-Market Facility for Sale of up to $150 Million of Common Stock
Galecto, Inc. was represented by Gibson Dunn in setting up an at-the-market facility for the selling of up to $150...
Gibson Dunn Advises Atossa Therapeutics on Establishing At-the-Market Facility for Sale of up to $50 Million of Common Stock
Atossa Therapeutics, Inc. was represented by Gibson Dunn in the establishment of an at-the-market facility for the sale of up...
Gibson Dunn Advises BVF Partners L.P. on up to $400 Million Financing for Immunic, Inc.
As the main investor in the up to $400 million private placement funding for Immunic, Inc., a late-stage biotechnology firm...
Gibson Dunn Advises Coastlands Capital on up to $40 Million Financing for AN2 Therapeutics, Inc.
As lead investor in the up to $40 million private placement funding for AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical business...
S&C Advises BMO Financial Group on Sale of its Transportation Finance and Vendor Finance Businesses to Stonepeak
BMO Financial Group consented to sell Stonepeak its Transportation Finance and Vendor Finance divisions, together with associated loan portfolios in...
Gibson Dunn Advises Dianthus Therapeutics on $719 Million Upsized Offering of Common Stock and Pre-Funded Warrants
Dianthus Therapeutics, Inc. was represented by Gibson Dunn in a public offering of its common stock and pre-funded warrants to...
Gibson Dunn Antitrust Team Advises Merck on $6.7 Billion Acquisition of Terns Pharmaceuticals, Inc.
Merck is receiving advice from a Gibson Dunn antitrust team about its $6.7 billion purchase of the clinical-stage oncology business...
Gibson Dunn Advises BVF Partners L.P. on up to $24.5 Million Financing for Entera Bio
For Entera Bio Ltd., a clinical stage company focused on creating oral peptide and protein replacement therapies for major unmet...
Akin Scales Global Private Equity Platform with Addition of Market-Leading Team in New York and London; Gerald Brant Named Head of US Private Equity
Today, Akin announced the entrance of a top-tier private equity team in New York and London, which includes Jonathan Hamill,...
